|
1
|
Firestein GS: Evolving concepts of
rheumatoid arthritis. Nature. 423:356–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: Key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Izquierdo E, Cañete JD, Celis R, Del Rey
MJ, Usategui A, Marsal S, Sanmartí R, Criado G and Pablos JL:
Synovial fibroblast hyperplasia in rheumatoid arthritis:
Clinicopathologic correlations and partial reversal by anti-tumor
necrosis factor therapy. Arthritis Rheum. 63:2575–2583. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim SH, Han SY, Azam T, Yoon DY and
Dinarello CA: Interleukin-32: A cytokine and inducer of TNFalpha.
Immunity. 22:131–142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Joosten LA, Netea MG, Kim SH, Yoon DY,
OppersWalgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello
CA and van den Berg WB: IL-32, a proinflammatory cytokine in
rheumatoid arthritis. Proc Natl Acad Sci USA. 103:3298–3303. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alsaleh G, Sparsa L, Chatelus E, Ehlinger
M, Gottenberg JE, Wachsmann D and Sibilia J: Innate immunity
triggers IL-32 expression by fibroblast-like synoviocytes in
rheumatoid arthritis. Arthritis Res Ther. 12:R1352010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heinhuis B, Koenders MI, van Riel PL, van
de Loo FA, Dinarello CA, Netea MG, van den Berg WB and Joosten LA:
Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid
arthritis synovial tissue amplifies an inflammatory cascade. Ann
Rheum Dis. 70:660–667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burrage PS, Mix KS and Brinckerhoff CE:
Matrix metalloproteinases: Role in arthritis. Front Biosci.
11:529–543. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feldmann M and Maini RN: The role of
cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology
(Oxford). 38 (Suppl 2):3–7. 1999.PubMed/NCBI
|
|
10
|
Abramson SB and Yazici Y: Biologics in
development for rheumatoid arthritis: relevance to osteoarthritis.
Adv Drug Deliv Rev. 58:212–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeong JG, Kim JM, Cho H, Hahn W, Yu SS and
Kim S: Effects of IL-1beta on gene expression in human rheumatoid
synovial fibroblasts. Biochem Biophys Res Commun. 324:3–7. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tao X, Cush JJ, Garret M and Lipsky PE: A
phase I study of ethyl acetate extract of the chinese antirheumatic
herb Tripterygium wilfordii hook F in rheumatoid arthritis.
J Rheumatol. 28:2160–2167. 2001.PubMed/NCBI
|
|
13
|
Qiu D and Kao PN: Immunosuppressive and
anti-inflammatory mechanisms of triptolide, the principal active
diterpenoid from the Chinese medicinal herb Tripterygium
wilfordii Hook. f. Drugs R D. 4:1–18. 2003. View Article : Google Scholar
|
|
14
|
Shibuya H, Yoshitomi H, Murata K, et al:
TNFα, PDGF and TGFβ synergistically induce synovial lining
hyperplasia via inducible PI3Kδ. Mod Rheumatol. 25:72–78. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Lu Y, Xiao C, Lu C, Niu X, He X,
Zhao H, Tan Y and Lu A: Comparison of toxic reaction of
Tripterygium wilfordii multiglycoside in normal and adjuvant
arthritic rats. J Ethnopharmacol. 135:270–277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tao X, Younger J, Fan FZ, Wang B and
Lipsky PE: Benefit of an extract of Tripterygium Wilfordii
Hook F in patients with rheumatoid arthritis: A double-blind,
placebo-controlled study. Arthritis Rheum. 46:1735–1743. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lequerré T, Jouen F, Brazier M, Clayssens
S, Klemmer N, Ménard JF, Mejjad O, Daragon A, Tron F, Le Loët X, et
al: Autoantibodies, metalloproteinases and bone markers in
rheumatoid arthritis patients are unable to predict their responses
to infliximab. Rheumatology (Oxford). 46:446–453. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gui M, Zhang H, Zhong K, Li Y, Sun J and
Wang L: Clinical significance of interleukin-32 expression in
patients with rheumatoid arthritis. Asian Pac J Allergy Immunol.
31:73–78. 2013.PubMed/NCBI
|
|
19
|
Scherer S, de Souza TB, de Paoli J, Brenol
CV, Xavier RM, Brenol JC, Chies JA and Simon D: Matrix
metalloproteinase gene polymorphisms in patients with rheumatoid
arthritis. Rheumatol Int. 30:369–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim KS, Choi HM, Oh H, Kim C, Jeong JS,
Yoo MC and Yang HI: Effect of taurine chloramine on the production
of matrix metalloproteinases (MMPs) in adiponectin - or
IL-1beta-stimulated fibroblast-like synoviocytes. J Biomed Sci. 17
(Suppl 1):S272010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lv QW, Zhang W, Shi Q, Zheng WJ, Li X,
Chen H, Wu QJ, Jiang WL, Li HB, Gong L, et al: Comparison of
Tripterygium wilfordii Hook F with methotrexate in the
treatment of active rheumatoid arthritis (TRIFRA): A randomised,
controlled clinical trial. Ann Rheum Dis annrheumdis-2013-204807.
2014.
|
|
22
|
Xu WD, Zhang M, Feng CC, Yang XK, Pan HF
and Ye DQ: IL-32 with potential insights into rheumatoid arthritis.
Clin Immunol. 147:89–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goda C, Kanaji T, Kanaji S, Tanaka G,
Arima K, Ohno S and Izuhara K: Involvement of IL-32 in
activation-induced cell death in T cells. Int Immunol. 18:233–240.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chan MA, Kohlmeier JE, Branden M, Jung M
and Benedict SH: Triptolide is more effective in preventing T cell
proliferation and interferon-gamma production than is FK506.
Phytother Res. 13:464–467. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sylvester J, Liacini A, Li WQ, Dehnade F
and Zafarullah M: Tripterygium wilfordii Hook F extract
suppresses proinflammatory cytokine-induced expression of matrix
metalloproteinase genes in articular chondrocytes by inhibiting
activating protein-1 and nuclear factor-kappaB activities. Mol
Pharmacol. 59:1196–1205. 2001.PubMed/NCBI
|
|
26
|
Bao J and Dai SM: A Chinese herb
Tripterygium wilfordii Hook F in the treatment of rheumatoid
arthritis: Mechanism, efficacy, and safety. Rheumatol Int.
31:1123–1129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tao X, Cush JJ, Garret M and Lipsky PE: A
phase I study of ethyl acetate extract of the chinese antirheumatic
herb Tripterygium wilfordii hook F in rheumatoid arthritis. J
Rheumatol. 28:2160–2167. 2001.PubMed/NCBI
|
|
28
|
Klimiuk PA, Sierakowski S, Domyslawska I
and Chwiecko J: Effect of repeated infliximab therapy on serum
matrix metalloproteinases and tissue inhibitors of
metalloproteinases in patients with rheumatoid arthritis. J
Rheumatol. 31:238–242. 2004.PubMed/NCBI
|
